We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Promising Efficacy and Toxicity Data For New Antibody Drug Conjugate

Product News   Oct 14, 2019

 
Promising Efficacy and Toxicity Data For New Antibody Drug Conjugate
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Custom Recombinant Monoclonal Antibody Development Service

Product News

AMSBIO announce a new rabbit and mouse recombinant monoclonal antibody development service based upon a revolutionary technology platform.

READ MORE

CN Bio Announces Commercial Launch of Its Metabolism and Safety Toxicity Testing Services

Product News

CN Bio today announced the commercial launch of its Drug Metabolism and Safety Toxicity Testing Services. The new toxicity testing services also provide researchers with additional support and bandwidth during the COVID-19 pandemic, when laboratories are not at full capacity.

READ MORE

Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services

Product News

Berlin, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, & Heidelberg Pharma AG, Ladenburg, Germany, today announced that Heidelberg Pharma has signed a Master Service Agreement for the antibodies used in two of their pipeline Antibody Targeted Amanitin Conjugate (ATAC) molecules.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE